Roche products were available in the Indian sub-continent much before partition. After Pakistan emerged on the world map, imports continued and after a few years some products started to be toll manufactured in Karachi. In the year 1984, the foundation of the Roche plant was laid in Korangi Industrial Area on the outskirts of Karachi. Within a span of three years the plant was constructed and Roche Pakistan started local manufacturing in October 1987.
In recent years, as Roche Pakistan strategic focus moved towards its biotechnology medicines meant for the treatment of cancer, hepatitis and chronic anaemia, most of the traditional pharmaceutical business alongwith the factory were divested in 2010.
Roche Pakistan Limited is part of the International F. Hoffmann-La Roche Group that was founded in 1896 in Basel, Switzerland. Roche has grown from a small drug laboratory into one of the world's leading research-based healthcare companies and is known for many innovative contributions to medicine.
Company Profile
Status of the Company: Public Unlisted Company
Company Registration Number: 0001857
Company NTN Number: 0711885-6
Name of Auditor: KPMG Taseer Hadi & Co.
Name of Legal Advisor: Vellani & Vellani, Fazleghani Associates
Shareholding Pattern: Wholly owned subsidiary of Roche Holding Limited, Switzerland
Board of Directors: Hafsa Shamsie, Farhan Bhatti, Robert Ferraro, Badaruddin F. Vellani, M. Waqas Siddiqui
M-PK-00001196
Today Roche Pakistan’s business covers both Pharmaceuticals and Diagnostics. In the pharma market Roche is ranked among the top companies while in the Diagnostic sector Roche is the market leader. The combined strengths of our diagnostics and pharmaceutical businesses, coupled with expertise in the emerging genetic sciences, equip us to develop integrated healthcare solutions and therapeutic approaches tailored to individual patients' needs. Roche's products and services address the entire healthcare spectrum, from screening for genetic risk factors to preventing, diagnosing and treating disease and monitoring the treatment response.
Arranged in two operative divisions; pharmaceuticals and diagnostics, our global mission today and tomorrow is to create exceptional added value in healthcare by focusing on our expertise in Diagnostics and Pharmaceuticals.